A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer (Q33337671)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

D Mavroudis

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

E Papadakis

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

M Veslemes

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

X Tsiafaki

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

J Stavrakakis

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

C Kouroussis

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

S Kakolyris

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

E Bania

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

J Jordanoglou

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

M Agelidou

10

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

J Vlachonicolis

11

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

V Georgoulias

12

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Greek Lung Cancer Cooperative Group

13

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

publication date

1 April 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

463-470

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011131303391

7 January 2021

based on heuristic

inferred from DOI database lookup

Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011131303391

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of small cell lung cancer: current state of the art.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011131303391

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011131303391

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel and G-CSF in previously untreated patients with extensive stage small-cell lung cancer: a phase II study of the North Central Cancer Treatment Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011131303391

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011131303391

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011131303391

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011131303391

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011131303391

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of broad drug resistance in small cell lung cancer cells and its reversal by paclitaxel

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011131303391

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011131303391

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin and etoposide (VP-16) as a single regimen for small cell lung cancer. A phase II trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011131303391

7 January 2021

based on heuristic

inferred from DOI database lookup

Small-cell lung cancer: patients included in clinical trials are not representative of the patient population as a whole.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011131303391

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011131303391

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin, etoposide, and paclitaxel in the treatment of patients with extensive small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011131303391

7 January 2021

based on heuristic

inferred from DOI database lookup

Multi-institutional phase I/II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011131303391

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1011131303391

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33337671&oldid=1947831438"